Anobis Asset GmbH
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Apollo Health Ventures
Apollo Health Ventures is a transatlantic early-stage Venture Capital firm actively co-founding and investing in transformative healthcare companies. Their primary focus is on companies targeting age-related diseases and aging itself. They believe that biotechnology is the solution for a healthier lifespan and reduced healthcare spending. They aim to impact human health within the next 10 years by enabling transformative healthcare companies in their scientific breakthroughs. The firm leverages a Venture Lab to identify company-building opportunities and maintains close ties with leading research institutions and researchers in the aging sector.
Apollo Ventures Holding GmbH
Apollo Health Ventures is a transatlantic early-stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself. The firm believes biotechnology is the solution for a healthier lifespan and reduced healthcare spending. By investing in and enabling transformative healthcare companies, Apollo aims to impact human health within the next 10 years.
Apricum Capital
Apricum Capital is a global transaction advisory and strategy consulting firm dedicated to the cleantech industry, established in 2008. The firm believes the shift to clean energy presents an opportunity to build stronger economies, smarter systems, and a better future. They connect cleantech companies with the right investors, guiding them to make informed decisions and capitalize on opportunities. Apricum achieves this by pairing companies, from startups to established players, with investors and experts to facilitate sustainable growth. They provide growth-oriented services, including mergers and acquisitions, fundraising, project finance, strategy development, business model design, and technology roadmaps. Apricum focuses exclusively on renewables and cleantech across the entire value chains. Their expertise spans market dynamics, drivers, economics, and engineering-level technical understanding. They have completed over 500 projects with a transaction volume involvement exceeding €4.0 billion, serving clients in over 30 countries. The firm has local representatives in 28 key renewable energy markets globally. Apricum offers transaction advisory and strategy consulting services to investors and corporates on M&A, fundraising, and growth strategy across clean energy markets. The firm combines deep technical and commercial expertise with a strong industry network and a proven track record, helping clients deploy capital effectively and enable informed investment decisions in the energy transition.
Aquarius Invest
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Arcus Capital
ARCUS Capital is a family equity investor focused on partnering with medium-sized companies in German-speaking regions. Unlike traditional investment funds, ARCUS is an owner-managed investment company with a flexible investment horizon and no pressure to sell successful investments, enabling sustainable long-term value creation. They operate independently, free from external constraints, and are sector-agnostic, investing with partners suited to each specific company. ARCUS offers more than just capital; they serve as active sparring partners, providing contacts and expertise to further develop companies. Their entrepreneurial approach allows for quick decision-making, and the ARCUS team invests their private capital to ensure alignment of interests with co-investors, typically families and entrepreneurs focused on societal responsibility and the values of partner companies, not solely on profit maximization. The firm leverages its management experience through projects related to strategy development, internationalization, and finance. ARCUS looks for opportunities arising from succession arrangements, spin-offs, changes in the shareholder base, MBOs, or MBIs, seeking majority stakes in companies with strong market positions and attractive growth potential.
Ariane IX AG
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Ark Capital
Gilion, operating under Ark Capital, aims to redefine the funding landscape by leveraging data and AI to assess companies dynamically and at scale, moving away from traditional banking's static models and manual processes. Their approach focuses on understanding companies often deemed "unbankable," revealing their potential through better analysis and decision-making tools. Gilion's initial focus was to build an internal platform to demonstrate the possibilities of faster, more transparent, and intelligent investment decision-making, built on intelligence that compounds. Now, they are opening this platform to the broader investment community and their respective verticals, to deliver faster and better funding decisions for all funders and builders.
Armira
Armira is an investment holding company focused on providing entrepreneurial capital for long-term partnerships. They aim to be the preferred investment partner for family investors and entrepreneurs seeking to invest in medium-sized businesses and resilient growth companies. For entrepreneurs looking for co-owners, they aim to be a trusted partner for the next growth phase. The firm manages approximately 5 billion EUR and invests in leading family businesses and growth companies in the DACH region and adjacent markets. Their investment approach is supported by an investor base consisting of families, entrepreneurs, and long-term entrepreneurial capital. Armira operates through three main investment strategies: Armira Mittelstand, Armira Growth, and Armira Opportunities. Armira Mittelstand invests in majority stakes in growing "Hidden Champions" in DACH, Northern Italy, and beyond. Armira Growth provides growth capital to European tech companies. Armira Opportunities focuses on significant minority investments in well-established family businesses within health, life sciences, or tech sectors.
Art-Invest Real Estate
Art-Invest Real Estate positions itself as a project developer, asset manager, and long-term investor focused on creating sustainable value in the real estate market. Their approach centers around innovation, creativity, and a commitment to projects that positively impact society and the environment. They emphasize creating added value for all stakeholders, not just for themselves, and aim to shape the future through responsible and sustainable development.
Ascenion
Ascenion GmbH is a knowledge and technology transfer company focused on academic life science research. They operate as a bridge between research institutions and industry, aiming to protect, develop, and commercialize innovative ideas. Ascenion initiates and finances start-ups, provides services to inventors and founders, and helps industry and investors discover opportunities for innovation. They manage a portfolio of over 700 technologies and research materials, facilitating the transfer of these assets to companies that can further develop and commercialize them. Their activities span from initial IP protection and development to financing and strategic support for start-ups, and ultimately to licensing and partnerships with established industry players. Ascenion's core strategy revolves around identifying promising research outputs from its partner institutes, securing intellectual property, and then de-risking and developing these technologies to a point where they are attractive for commercialization. This often involves initiating and supporting start-up companies, providing them with seed funding, management expertise, and access to Ascenion's network of industry contacts. The firm also works closely with established companies to license and co-develop technologies, creating value for both the research institutions and the industry partners. Ascenion's partnership with the LifeScience Foundation underlines its commitment to translating academic discoveries into real-world applications. The company plays a critical role in the life science ecosystem by accelerating the development and commercialization of innovative technologies, ultimately contributing to advancements in healthcare and other related fields. They also actively engage in knowledge sharing and collaboration through workshops and events, fostering a vibrant community of technology transfer professionals and entrepreneurs.
Atlantic.vc
Atlantic invests in bold, early-stage founders and scientists pursuing groundbreaking technologies that defy conventional categories. The firm specializes in pre-seed rounds across Europe, backing 'unknowns' that challenge the status quo and have the potential to become industry-defining innovations.
Auctus Alternative Investments
AUCTUS, founded in 2001, positions itself as the leading investment firm for the European Mittelstand (SMEs). Their investment strategy centers around creating market leaders through sector-specific concepts, focusing on succession solutions, buy-and-build strategies, and corporate spin-offs. They primarily take majority stakes in medium-sized companies or provide capital for growth and acquisitions. The firm's name, derived from the Latin word for 'sustainable growth,' reflects their commitment to long-term value creation in their portfolio companies through revenue and profit growth. AUCTUS's approach involves actively partnering with the management teams of their portfolio companies to drive operational improvements and strategic initiatives. They emphasize a hands-on approach, leveraging their industry expertise and network to accelerate growth and market leadership. The firm is structured as a partnership, with ownership residing within the team, aligning their interests with those of their investors and portfolio companies. AUCTUS differentiates itself through its deep sector knowledge, operational expertise, and entrepreneurial approach. Their focus on the Mittelstand allows them to identify and capitalize on opportunities in a segment often overlooked by larger private equity firms. The high percentage of capital originating from the AUCTUS team itself demonstrates a strong commitment and belief in their investment strategy.
Auxxo
Auxxo is a venture capital firm that invests in female-led startups in Europe. They aim to address the gender funding gap in the startup ecosystem by providing capital and support to women entrepreneurs. They focus on companies with diverse teams and the potential for high growth. They invest across various sectors and stages, supporting startups from pre-seed to Series A. Auxxo's investment strategy is driven by the belief that female-led companies often outperform their male-led counterparts, leading to better returns. They provide portfolio companies with access to their network, mentorship, and operational support, aiming to accelerate their growth and success. Auxxo is committed to fostering a more inclusive and equitable startup ecosystem.
Axel Springer Digital Ventures
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
BACB Beteiligungsgesellschaft
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
BASF
BASF, as a corporate venture entity, focuses on creating change through breakthrough technologies and bold ideas, enabling sustainable solutions for the climate, partners, and future generations. Their strategy, "Winning Ways," aims to position BASF as the preferred chemical company enabling customers' green transformation. They prioritize economic success, environmental protection, and social responsibility, aligning their core businesses across Chemicals, Materials, Industrial Solutions, and Nutrition & Care segments. Standalone businesses are bundled within Surface Technologies and Agricultural Solutions. BASF's approach involves strategic portfolio management, demonstrated by the recent divestiture of its hydrosulfite-related assets to Silox, signaling a strategic shift and streamlining efforts. This allows them to focus on core areas, maintain market leadership in other inorganic chemicals, and optimize resource allocation. The investment in expanding dispersion production in Durban, South Africa, highlights their commitment to growth in emerging markets and supporting customer needs in architectural coatings, construction, and paper industries. They emphasize reliable supply chains and responsiveness to local market demands. Central to their strategy is driving sustainable solutions, showcased by their ambition to enable customers' green transformation. This involves developing innovative products and technologies that minimize environmental impact and promote resource efficiency. By aligning with global trends towards sustainability and circular economy models, BASF seeks to create long-term value for stakeholders and contribute to a more sustainable future. They invest in research and development to create chemistry for a sustainable future. They actively seek to accomplish great things together, aiming to inspire and drive change by fostering a culture that attracts and retains top talent. BASF offers various career opportunities for individuals looking to contribute to their mission. Their comprehensive approach involves strategic investments, streamlined operations, and a steadfast commitment to sustainability, all contributing to their ambition of being the preferred chemical company.
BASF Venture Capital
BASF Venture Capital (BVC) invests in young companies and funds that are developing technologies that are strategically relevant to BASF's core business. Their investment focus spans across areas like CO2 mitigation, circular economy, new materials, biotechnology, artificial intelligence and software solutions, and digital farming. BVC aims to identify and drive innovative solutions related to BASF's strategic priorities, fostering and financing startups to create long-term value and maintain competitiveness. They emphasize measurable impact over momentum, connecting strategic priorities with credible external innovation. Their goal is to bridge the gap between the startup world and BASF's core operations, leveraging external innovation to enhance BASF's competitive edge and contribute to its growth strategy.
BG Thüringen
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
BIOVENTURE Consulting GmbH
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
BMH Beteiligungs-Managementgesellschaft Hessen
Based on the available information, BMH Beteiligungs-Managementgesellschaft Hessen (BMH Hessen) appears to focus on providing equity financing to businesses in the Hessen region of Germany. Their investment strategy includes supporting tech startups, small and medium-sized enterprises (SMEs), and companies in various sectors including healthtech, AI, proptech, and deep tech. BMH seems to participate in multiple funding rounds, from pre-seed and seed to growth stages, and also supports succession solutions for established companies. They actively manage the HessenFonds, indicating a commitment to fostering regional economic growth and innovation within Hessen. They look for companies that address significant needs or offer innovative solutions in their respective markets. The firm also co-invests with other VCs like HTGF (High-Tech Gründerfonds). BMH is interested in supporting succession planning and supporting smaller SMEs.
BMH Beteiligungs-Managementgesellschaft Hessen mbH
BMH invests in Hessian companies across diverse sectors, focusing on equity and mezzanine capital to support startups, innovation, growth, and M&A. The firm emphasizes long-term partnerships, preserving company independence while strengthening financial stability and access to additional funding. BMH leverages its network to provide strategic connections in finance, industry, and academia.
BMH Beteiligungs-Managementgesellschaft Hessen mbH (BMH)
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
BTH Technologie Holding
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.